Journal article · 2022 · Open access
HPR155 The Use of Patient-Reported Outcomes for New Drugs Approval in Europe: A Review of European Public Assessment Reports From 2017 to 2021
Value in Health, 25(12), S260–S261 · Published 1 December 2022 · DOI 10.1016/j.jval.2022.09.1284
In brief
“HPR155 The Use of Patient-Reported Outcomes for New Drugs Approval in Europe: A Review of European Public Assessment Reports From 2017 to 2021” is a 2022 journal article by Michela Meregaglia and 3 co-authors, published in Value in Health. OpenAlex counts 0 citations as of 22 November 2026. It is open access: the full text is free to read at Value in Health.
- Citations
- 0
- Authors
- 4
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Meregaglia, M., Malandrini, F. B., Borroni, C., & Ciani, O. (2022). HPR155 The Use of Patient-Reported Outcomes for New Drugs Approval in Europe: A Review of European Public Assessment Reports From 2017 to 2021. Value in Health, 25(12), S260–S261. https://doi.org/10.1016/j.jval.2022.09.1284
MLA 9
Meregaglia, Michela, et al. “HPR155 The Use of Patient-Reported Outcomes for New Drugs Approval in Europe: A Review of European Public Assessment Reports From 2017 to 2021.” Value in Health, vol. 25, no. 12, 2022, pp. S260–S261. https://doi.org/10.1016/j.jval.2022.09.1284.
Chicago
Meregaglia, Michela, Francesco Benito Malandrini, Cesare Borroni, and Oriana Ciani. 2022. “HPR155 The Use of Patient-Reported Outcomes for New Drugs Approval in Europe: A Review of European Public Assessment Reports From 2017 to 2021.” Value in Health 25 (12): S260–S261. https://doi.org/10.1016/j.jval.2022.09.1284.
Harvard
Meregaglia, M. et al. (2022) ‘HPR155 The Use of Patient-Reported Outcomes for New Drugs Approval in Europe: A Review of European Public Assessment Reports From 2017 to 2021’, Value in Health, 25(12), pp. S260–S261. doi:10.1016/j.jval.2022.09.1284.
IEEE
M. Meregaglia, F. B. Malandrini, C. Borroni, and O. Ciani, “HPR155 The Use of Patient-Reported Outcomes for New Drugs Approval in Europe: A Review of European Public Assessment Reports From 2017 to 2021,” Value in Health, vol. 25, no. 12, pp. S260–S261, 2022, doi: 10.1016/j.jval.2022.09.1284.
BibTeX
@article{meregaglia2022patient,
title = {{HPR155 The Use of Patient-Reported Outcomes for New Drugs Approval in Europe: A Review of European Public Assessment Reports From 2017 to 2021}},
author = {Meregaglia, Michela and Malandrini, Francesco Benito and Borroni, Cesare and Ciani, Oriana},
journal = {Value in Health},
year = {2022},
volume = {25},
number = {12},
pages = {S260--S261},
doi = {10.1016/j.jval.2022.09.1284},
url = {https://doi.org/10.1016/j.jval.2022.09.1284}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- patient-reported outcomes
- patient-reported outcome measures
- drug approval
- regulatory decision-making
- European Public Assessment Reports
- new chemical entities
- regulatory science
- European Medicines Agency
Work with this paper
Most-cited papers in Economics, Econometrics and Finance
- Theory of the firm: Managerial behavior, agency costs and ownership structureMichael C. Jensen, William H. Meckling · Journal of Financial Economics · 1976 · 77,585 citations
- Institutions, Institutional Change and Economic PerformanceDouglass C. North · Cambridge University Press eBooks · 1990 · 34,377 citations
- The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.John E. Ware, Cathy Donald Sherbourne · PubMed · 1992 · 33,943 citations
- Some Tests of Specification for Panel Data: Monte Carlo Evidence and an Application to Employment EquationsManuel Arellano, Stephen R. Bond · The Review of Economic Studies · 1991 · 33,778 citations
- Co-Integration and Error Correction: Representation, Estimation, and TestingRobert F. Engle, C.W.J. Granger · Econometrica · 1987 · 32,847 citations
Questions about this paper
How do I cite this paper in APA style?
Meregaglia, M., Malandrini, F. B., Borroni, C., & Ciani, O. (2022). HPR155 The Use of Patient-Reported Outcomes for New Drugs Approval in Europe: A Review of European Public Assessment Reports From 2017 to 2021. Value in Health, 25(12), S260–S261. https://doi.org/10.1016/j.jval.2022.09.1284
How many times has this paper been cited?
0 times, according to OpenAlex on 22 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Value in Health: sign in and open the full text from this page.
Who wrote this paper?
Michela Meregaglia, Francesco Benito Malandrini, Cesare Borroni, Oriana Ciani.
What is the DOI of this paper?
10.1016/j.jval.2022.09.1284, permanently at https://doi.org/10.1016/j.jval.2022.09.1284. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 22 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.